4 ms·
I'm not from an EU country, but I'm familiar with it. A lot of European countries do a health technology assessment to determine the cost effectiveness. If it
by refurb 9y ago
I'm not from an EU country, but I'm familiar with it.
A lot of European countries do a health technology assessment to determine the cost effectiveness. If it's not cost effective, they don't pay for it.
Glybera was approved in the EU and Germany pays for it and it costs $1M.[1] Of course, very very few patients have or will be treated with it.
[1]http://blogs.nature.com/tradesecrets/2015/03/03/1-million-price-tag-set-for-glybera-gene-therapy http://blogs.nature.com/tradesecrets/2015/03/03/1-million-pr...